Silence Therapeutics (NASDAQ:SLN), Alnylam Pharmaceuticals…
The US Food and Drug Administration (FDA) has granted approval revance therapeutics‘ RVNC Lead asset DAXXIFY (DaxibotulinumtoxinA-lanm) for injection for the temporary improvement of moderate